Home›Companies›Biotech & Pharma›Rebel Medicine

Rebel Medicine Inc

Develops non-opioid pain medicines for people experiencing acute or post-surgical pain.

Updated Nov 10, 2026·Latest SEC filing Jun 4, 2026·Suggest an edit

About Rebel Medicine

Rebel Medicine is a private company based in Salt Lake City, Utah. It has reported $8,787,200 raised in one offering on Form D since February 2025. Its chief executive is Brett Davis.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Feb 7, 2025Feb 21, 2025amended Jun 4, 2026$8,787,200of $8.9M target43$204KEquityRule 506(b)Form D/A ↗1 earlier filing

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Rebel Medicine's Form D filed Jun 4, 2026.

CL
Caleb Lade
Executive officer and director
KP
Kevin Passey
Director
BD
Brett Davis
Co-Founder & CEO, director
MN
Mai Nguyen
Director

Sources

  1. SECRebel Medicine Inc Form D, filed Feb 21, 2025
  2. SECRebel Medicine Inc filing history
  3. PressRebel Medicine financing and clinical development announcement